Home-based Care Coaching for Chronic Obstructive Pulmonary Disease
(SAMBA COPD Trial)
Trial Summary
What is the purpose of this trial?
The Icahn School of Medicine at Mount Sinai will conduct a randomized controlled trial of a self-management support intervention for predominantly minoritized and low-income adults with chronic obstructive pulmonary disease (COPD). The trial will focus on comprehensive screening and targeted management of barriers to COPD control, incorporating home-based pulmonary rehabilitation and oral steroid and antibiotic prescribing for pre-emptive treatment of COPD exacerbations. The research team will compare this intervention with an attention control group to evaluate the effects on medication adherence, COPD symptoms, inhaler technique, physical activity and exercise capacity at 6 months, and at 12 months to examine sustainability of treatment effects. The research team will also examine hospitalizations and emergency department visits at 12 months. The study will recruit 300 participants from the Mount Sinai Health System in Manhattan, Queens, and Brooklyn, ensuring diverse representation. Health coaches from the VNS Health will deliver the intervention, guided by a detailed training manual. Weekly conference calls will address logistical and protocol-related issues.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop your current medications. However, since the study focuses on medication adherence, you may need to continue taking your prescribed COPD medications.
What data supports the effectiveness of the treatment Comprehensive Patient-Centered Home-based Care Coaching for Chronic Obstructive Pulmonary Disease?
Research shows that home-based pulmonary rehabilitation and health coaching can significantly improve the quality of life, self-management, and physical activity in patients with COPD. A study found that remote monitoring with health coaching led to meaningful improvements in physical and emotional well-being, as well as reduced symptoms of depression and anxiety.12345
Is home-based care coaching for COPD safe for humans?
Research indicates that home-based pulmonary rehabilitation and health coaching for COPD are generally safe, even for patients with very severe conditions. These programs have been tested and found to be a feasible and effective option for improving quality of life and self-management without significant safety concerns.56789
How is the Home-based Care Coaching treatment for COPD different from other treatments?
This treatment is unique because it offers a home-based approach to pulmonary rehabilitation, combining health coaching and self-management support, which can improve patient adherence and access compared to traditional center-based programs. It also includes remote monitoring and personalized coaching by healthcare professionals, which helps patients manage their condition more effectively at home.1681011
Research Team
Alex Federman, MD, MPH
Principal Investigator
Ichan School of Medicine at Mount Sinai, The Mount Sinai Hospital
Eligibility Criteria
This trial is for adults with COPD who are mostly from minoritized and low-income backgrounds. Participants should be able to follow a home-based care program, including pulmonary rehabilitation and medication management. The study excludes individuals who do not meet the specific inclusion criteria set by the researchers.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive comprehensive screening and targeted management of barriers to COPD control, incorporating home-based pulmonary rehabilitation, oral steroid and antibiotic prescribing for pre-emptive treatment of COPD exacerbations
Follow-up
Participants are monitored for sustainability of treatment effects, hospitalizations, and emergency department visits
Treatment Details
Interventions
- Comprehensive Patient-Centered Home-based Care Coaching
Comprehensive Patient-Centered Home-based Care Coaching is already approved in United States for the following indications:
- Chronic Obstructive Pulmonary Disease (COPD) management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Icahn School of Medicine at Mount Sinai
Lead Sponsor
VNS Health
Collaborator
Baystate Medical Center
Collaborator
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator